| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/21/2006 | CA2602088A1 Biomarkers for ovarian cancer and endometrial cancer: hepcidin |
| 09/21/2006 | CA2601677A1 Gene disruptions, compositions and methods relating thereto |
| 09/21/2006 | CA2601668A1 Novel soluble epcr protein of non-proteolytic origin and use thereof |
| 09/21/2006 | CA2601115A1 Antibodies against candida antigens |
| 09/21/2006 | CA2600844A1 Macromolecules comprising a thioether cross-link |
| 09/21/2006 | CA2600568A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | CA2600505A1 Anti-mesothelin antibodies |
| 09/20/2006 | EP1702986A1 BASB013 DNA and proteins from Neisseria meningitidis |
| 09/20/2006 | EP1702985A2 Preferred segments of neural thread protein and methods of using the same |
| 09/20/2006 | EP1702984A2 A method for detecting prostate cancer |
| 09/20/2006 | EP1702982A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 09/20/2006 | EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2006 | EP1702625A1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 09/20/2006 | EP1702518A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 09/20/2006 | EP1702069A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 09/20/2006 | EP1701979A2 Optimized antibodies that target the epidermal growth factor receptor |
| 09/20/2006 | EP1701977A2 Sars coronavirus s proteins and uses thereof |
| 09/20/2006 | EP1701950A1 Ecstasy haptens and immunogens |
| 09/20/2006 | EP1701949A2 Assay for entactogens |
| 09/20/2006 | EP1701948A1 Assay for entactogens |
| 09/20/2006 | EP1701739A2 Use of agents derived from ceacam1 for the treatment of inflammatory diseases |
| 09/20/2006 | EP1651674A4 Ups as modifiers of the beta catenin pathway and methods of use |
| 09/20/2006 | EP1432792B1 Histone deacetylase 9 |
| 09/20/2006 | EP1292621B1 Compositions for treating autoimmune disease |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP1051191B1 CD154 BLOCKADE THERAPY FOR PANCREATIC ISLET TISSUE TRANSPLANTATION in primates |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0774004B1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 09/20/2006 | CN1836041A Look-through mutagenesis |
| 09/20/2006 | CN1835977A CD20-binding polypeptide compositions |
| 09/20/2006 | CN1835976A Aglycosyl anti- CD154 (CD 40 ligand) antibodies and uses thereof |
| 09/20/2006 | CN1835975A Modified human IGF-1R antibodies |
| 09/20/2006 | CN1835974A Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 09/20/2006 | CN1835973A Compositions and methods for treatment of cryptococcosis |
| 09/20/2006 | CN1835972A Combination therapy for B cell disorders |
| 09/20/2006 | CN1835968A Compositions and methods for increasing bone mineralization |
| 09/20/2006 | CN1835769A KIM-1 antagonists and use to modulate immune system |
| 09/20/2006 | CN1835679A Process for producing human-origin immunocompetent cell |
| 09/20/2006 | CN1834244A Full length polynucleotide sequence of new allelic gene A*110104 of encoded human leucocyte antigen A*11 and uses thereof |
| 09/20/2006 | CN1276085C Coding sequence and application of konjaku agglutinic protein |
| 09/19/2006 | US7109320 Nucleic acid molecules encoding human tumor necrosis factor α-specific antibodies |
| 09/19/2006 | US7109310 Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs |
| 09/19/2006 | US7109309 Peptide fructose and protein conjugate with the same |
| 09/19/2006 | US7109308 Inhibiting tumor growth, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis; diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein |
| 09/19/2006 | US7109307 Nucleotide sequences coding polypeptide for use in the treatent of inflammatory disorders |
| 09/19/2006 | US7109305 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 09/19/2006 | US7109304 Humanized anti-CD19 antibodies |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109302 Antibodies that specifically bind to GMAD |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109182 Synthetic oligomannosides, preparation and uses thereof |
| 09/19/2006 | US7109006 Virulence of Streptococci |
| 09/19/2006 | US7109003 Methods for expressing and recovering human monoclonal antibodies to CTLA-4 |
| 09/19/2006 | US7109002 obtained by recombinant expression of DNA of human herpes virus type 8, and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma |
| 09/19/2006 | US7108992 Detecting activated kinase in sample; obtain sample containing kinase, determine phosphorylation state of serine, phosphorylation of preferential serine indicates active state |
| 09/19/2006 | US7108989 Therapy |
| 09/19/2006 | US7108986 A diagnostic agent comprising a reporting molecule attached to the binding molecule for detecting human cancers |
| 09/19/2006 | US7108981 Administering monoclonal antibody that specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), wherein the monoclonal antibody is produced by a hybridoma in a pharmaceutically acceptable carrier for therapy of Kaposi's sarcoma-associated herpesvirus infection |
| 09/19/2006 | US7108967 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection |
| 09/19/2006 | US7108858 Immunological protein |
| 09/19/2006 | US7108852 Methods of treating inflammation using antibodies to M-CSF |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/14/2006 | WO2006096663A2 Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease |
| 09/14/2006 | WO2006096491A2 Anti-ctla-4 antibody compositions |
| 09/14/2006 | WO2006096488A2 Composition comprising human igg2 antibody and chelating agent |
| 09/14/2006 | WO2006096451A2 Methionine sulfoxide antibodies |
| 09/14/2006 | WO2006096039A1 Monoclonal antibody specific to anthrax toxin |
| 09/14/2006 | WO2006095446A1 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 09/14/2006 | WO2006095180A2 Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars |
| 09/14/2006 | WO2006095128A2 Rodent pest control |
| 09/14/2006 | WO2006095041A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 09/14/2006 | WO2006094973A1 Neuropeptides |
| 09/14/2006 | WO2006094828A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 09/14/2006 | WO2006094724A2 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 09/14/2006 | WO2006094704A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/14/2006 | WO2006078268A3 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 09/14/2006 | WO2006075142A3 FORMS OF FACTOR XIIa |
| 09/14/2006 | WO2006074071A8 Framework residue substituted humanized col-1 antibodies and their use |
| 09/14/2006 | WO2006068987A3 Uses of il-23 antagonists in the treatment of diabetes mellitus |
| 09/14/2006 | WO2006061242A3 Use of pta peptides for stratification of individuals having cancer |
| 09/14/2006 | WO2006039258A3 Human antibodies against parathyroid hormone |
| 09/14/2006 | WO2006023210A3 Gp132: mehods and compositions for treating cancer |
| 09/14/2006 | WO2005117936A3 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/14/2006 | WO2005089807A3 Antibody calicheamicin conjugates for passive targeting |
| 09/14/2006 | WO2005086875A3 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/14/2006 | WO2005011376A3 Altered antibodies having improved antigen-binding affinity |
| 09/14/2006 | WO2004098489A3 Compositions and methods for modulation of specific epitopes of hsp60 |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | US20060206947 Heterodimeric protein binding compositions |
| 09/14/2006 | US20060205934 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 09/14/2006 | US20060205926 Human growth hormone domains |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205091 Protein biopolymer markers predictive of insulin resistance |
| 09/14/2006 | US20060205072 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 09/14/2006 | US20060205069 Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells |